Last updated on June 2020

Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis

Brief description of study

A 12-month study to compare the efficacy and safety of abaloparatide-sMTS with abaloparatide-subcutaneous (SC)

Detailed Study Description

This study aims to evaluate the non-inferiority of abaloparatide-sMTS 300 g compared to abaloparatide-SC 80 g based on lumbar spine bone mineral density (BMD) at 12 months and to evaluate the safety and tolerability of abaloparatide-sMTS in the treatment of postmenopausal women with osteoporosis

Clinical Study Identifier: NCT04064411

Find a site near you

Start Over

Clinical Research Consortium

Tempe, AZ United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.